Published April 2002 | Version v1
Journal article

The application of 99Tcm-MIBI scintimammography to diagnose multidrug resistance of breast cancer

Creators

  • 1. Zhengzhou Univ., Zhengzhou (China). Dept. of Nuclear Medicine, The First Affiliated Hospital

Description

The author discussed the main mechanism of multidrug resistance of breast cancer tissues, and the correlation between technetium-99m sestamibi (99Tcm-MIBI) breast imaging results, with the expression of drug resistance proteins P-glycoprotein and glutathione-S-transferase-π in human breast cancer. Through not all the results reported before matched each other, as a kind of a noninvasive simple functional test imaging technology in vitro, SPECT can be used to diagnose P-glycoprotein expression in breast cancer, and can be used to predict chemotherapy response

Additional details

Publishing Information

Journal Title
Foreign Medical Sciences. Section of Radiation Medicine and Nuclear Medicine
Journal Volume
26
Journal Issue
2
Journal Page Range
p. 67-71
ISSN
1001-098X